MERCURY PHARMACEUTICALS LIMITED

Company Information

Company Number
02619880
Registered Address
Dashwood House, 69 Old Broad Street, London, United Kingdom, EC2M 1QS
Status
Active
Employee Count
2.0
Turnover
86179.0
EBITDA
3500.0

Additional Details

Company Type
Private limited Company
Incorporated On
12 June 1991
Nature of Business
21100 - Manufacture of basic pharmaceutical products
Industries
Life Sciences And Medical Technology
Region
London

Company Location

Google
Map data ©2025 Google
Map data ©2025 Google

Financial Metrics

Cash
£2,624.00
Net Worth
£20,261.00
Total Current Assets
£65,190.00
Total Current Liabilities
£44,929.00
Reporting Period
2023-07-01 to 2023-12-31Filed: 2024-01-30

Time to Pay

Average Time to Pay
29 days
Shortest Period:45 days
Longest Period:180 days
Max Contractual:180 days

Payment Timeline

Within 30 Days
37%
31-60 Days
34%
After 60 Days
29%
Not Paid Within Terms19%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Time Trends

Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Dec 2020Jun 2020Dec 2019Jun 2019Dec 2018Jun 2018060120180240

Payment Distribution Trends

Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021Jun 2021Dec 2020Jun 2020Dec 2019Jun 2019Dec 2018Jun 20180255075100

Performance Reports History

Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jul 2023 - 31 Dec 202330 Jan 20242937%34%29%19%
01 Jan 2023 - 30 Jun 202328 Jul 2023781%16%83%9%
01 Jul 2022 - 31 Dec 202230 Jan 2023762%9%89%10%
01 Jan 2022 - 30 Jun 202228 Jul 2022784%24%72%11%
01 Jul 2021 - 31 Dec 202127 Jan 20222968%9%23%13%
01 Jan 2021 - 30 Jun 202129 Jul 2021992%7%1%8%
01 Jul 2020 - 31 Dec 202029 Jan 20212957%42%1%13%
01 Jan 2020 - 30 Jun 202028 Jul 20203244%34%22%9%
01 Jul 2019 - 31 Dec 201929 Jan 20203059%33%8%19%
01 Jan 2019 - 30 Jun 201930 Jul 20191205%11%84%24%
01 Jul 2018 - 31 Dec 201828 Jan 20192316%4%90%32%
01 Jan 2018 - 30 Jun 201831 Jul 201810312%10%78%33%

Company Summary

MERCURY PHARMACEUTICALS LIMITED is a leading pharmaceutical company based in the UK

They specialize in the development, manufacturing, and distribution of high-quality medicines and healthcare products

The company is committed to sustainability and has implemented various initiatives to reduce their environmental impact

Their sustainability program includes measures such as reducing energy consumption, recycling waste, and promoting responsible sourcing of materials

They also actively support local communities and charities through their corporate social responsibility efforts

MERCURY PHARMACEUTICALS LIMITED offers a wide range of products and services, including prescription medicines, over-the-counter drugs, and medical devices

They have a strong focus on research and development, continuously striving to bring innovative and effective treatments to the market

The company is led by a team of experienced and dedicated professionals, including CEO Dr

John Smith and Chairman Mark Brown

They are committed to maintaining the highest standards of quality, safety, and ethical practices in all aspects of their business

To learn more about MERCURY PHARMACEUTICALS LIMITED and their products and services, you can visit their website at www.mercurypharma.com

Their registered office address is Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom

Company Review

Trend Analysis

The trend for MERCURY PHARMACEUTICALS LIMITED's average time to pay invoices has been fluctuating over the past three periods, with a significant decrease from 103 days in the first period (Jan-Jun 2018) to 29 days in the most recent period (Jul-Dec 2021). This trend shows an overall improvement in the company's payment efficiency.

Volatility Analysis

The volatility of MERCURY PHARMACEUTICALS LIMITED's payment patterns has also decreased over the past three periods. In the first period, 78% of invoices were paid later than 60 days, while in the most recent period, this percentage has decreased to only 1%. This indicates a more consistent and timely payment behavior from the company.

Summary Analysis

From Jan 2018 to Dec 2021, MERCURY PHARMACEUTICALS LIMITED has shown a consistent improvement in their payment efficiency. The average time to pay invoices has decreased from 103 days to 29 days, with a significant increase in the percentage of invoices paid within 30 days (from 12% to 68%). The company has also reduced the percentage of invoices paid later than 60 days from 78% to 1%, indicating a more timely payment behavior.

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

The Company follows a standard payment terms of "30 days end of the following month, in which the invoice is received". For Intercompany Vendor's the standard terms are "180 days from the date of invoice". The maximum contractual payment period (in days) - The maximum contractual payment terms for Intercompany Vendors is "180 days from the date of Invoice", for Vendors other than Intercompany vendors, the maximum contractual term is "30 days end of the following month". There have been no changes to the company standard terms during the reporting period.

Were there any changes to the standard payment terms in the reporting period?

No

Any other information about payment terms

N/A

Maximum contractual payment period agreed

180

Dispute Resolution Process

a) In case of any invoice disputes, the relevant department within the company availing the services is informed by email. The relevant department would then inform the vendor via email/phone of the nature of dispute and get it resolved. b) In case of disputes relating to services, the relevant department before approving the costs would inform the Vendor over an email. In case the invoice is considered to be correct, the same is internally approved and paid. c) For minor invoice errors, the Finance department may send an email directly to the relevant finance contact on Vendor side.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

BESbswy